Press Release: Chief Executive Officer Yrjö Närhinen to Terveystalo’s Annual General Meeting of Shareholders 2018: It is now time to develop the Finnish healthcare system further


You May Also Like

Tetra Bio-Pharma Targets Multi-Billion Dollar Fibromyalgia Market

Co-development deal announced with Germany’s Storz & Bickel aims to improve delivery of cannabinoid-based ...

Cesca Therapeutics to Present at the Inaugural Cell and Gene Exchange 2017

RANCHO CORDOVA, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...